Latest News

Don't Miss News

Neuren Australian Clinical Trial

Neuren Australian Clinical Trial

admin Mar 30,2021

Welcome to Neuren Pharmaceuticals (www.neurenpharma.com; ASX:NEU). Neuren is a Melbourne-based company at the forefront of efforts to develop effective treatments for rare, paediatric neurodevelopmental disorders.  Over the last few years, they’ve successfully steered their first drug (Trofinetide) into Phase 3 clinical trials (the last stage before approval) for the treatment of Rett syndrome.  The final …

Centre of Excellence

Centre of Excellence

Feb 15,2021
Roche Clinical trial

Roche Clinical trial

Jun 23,2020

Other News

Global Angelman Syndrome Registry collaboration

Global Angelman Syndrome Registry collaboration

Dec 20,2019

We are proud to collaborate with the Angelman Syndrome Foundation, the Dup15q Alliance in Linking Angelman and Dup15q Data for Expanded Research (LADDER).